Orris

IgE

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
Reading File
Loading Image
Here is a comprehensive overview of Immunoglobulin E (IgE) drawn from multiple authoritative textbooks:

IgE (Immunoglobulin E)

Structure

IgE is the least abundant immunoglobulin in serum, comprising only ~0.0005% of total serum immunoglobulin. Its unique structural features set it apart from other isotypes:
  • Heavy chain: epsilon (ε) chain - structurally distinct from other Ig isotypes
  • Molecular formula: ε₂L₂ (two epsilon heavy chains + two light chains)
  • Molecular weight: ~190,000 Da (ε chain alone: ~70,000 Da)
  • Extra domain: Has an additional Cε4 domain, giving it higher molecular weight than IgG
  • Carbohydrate content: ~18% (more heavily glycosylated than IgG)
  • Valency: Functional valency of 2 (bivalent)
  • No complement fixation (classic pathway)
  • No placental transfer
Table 56.2, Henry's Clinical Diagnosis and Management by Laboratory Methods

Serum Half-Life and Distribution

PropertyValue
Serum half-life1-5 days
IgG serum half-life (comparison)~20 days
Catabolic rate>70% per day
Tissue-bound (mast cell) half-lifeUp to several months
The very low serum concentration reflects both avid binding to effector cells and a high catabolic rate. Once bound to mast cells, IgE persists for months.

IgE Class Switching and Production

Cellular and molecular interactions regulating IgE synthesis - showing APC, Th2 CD4+ T cell, and IgE B cell interactions with IL-4/JAK-STAT signaling driving class switch recombination to the epsilon heavy chain
IgE production requires a two-signal B cell activation:
  1. IL-4 and IL-13 (from Th2/TFH cells) drive class switch recombination to the ε heavy chain via JAK-STAT6 signaling
  2. CD40L-CD40 interaction (T cell contact signal) provides a costimulatory signal
Key transcription factors and genes involved:
  • IL-4, IL-13, IL-4Rα, STAT6 - the core molecular determinants of atopy
  • GATA-3 - Th2 differentiation
  • Class II HLA loci on chromosome 6p - influence sensitization to specific allergens

FcεRI - The High-Affinity IgE Receptor

IgE exerts its biological effects primarily via FcεRI (high-affinity Fc epsilon receptor I):
  • Expressed on mast cells and basophils
  • IgE binds to FcεRI via its Fc region (the Cε3 and Cε4 domains)
  • Binding is extremely avid - this "loads" mast cells with antigen-specific IgE
  • When antigen cross-links two or more FcεRI-bound IgE molecules, degranulation is triggered
There is also a low-affinity receptor FcεRII (CD23) expressed on B cells, monocytes, and eosinophils, which regulates IgE synthesis.

Mechanism of Immediate Hypersensitivity (Type I)

Sensitization to an inhaled allergen (Der p 1 house dust mite) - four-panel diagram showing: allergen entry through tight junction cleavage, dendritic cell antigen presentation, TFH/Th2-driven B cell IgE class switch, IgE travel to mucosa and mast cell binding, and finally allergen cross-linking of mast cell-bound IgE causing degranulation and allergic symptoms

Phase 1: Sensitization

  1. Allergen penetrates epithelial barrier
  2. Dendritic cells capture allergen and traffic to lymph node
  3. TFH/Th2 cells are primed; IL-4 and IL-13 are produced
  4. B cells undergo class switch to produce allergen-specific IgE
  5. IgE travels to tissues and binds FcεRI on mast cells

Phase 2: Elicitation (re-exposure)

  1. Allergen re-enters the tissue
  2. Allergen cross-links mast cell-surface IgE
  3. Mast cell degranulation occurs within minutes
  4. Pre-formed mediators released: histamine, tryptase, chondroitin sulfates, TNF-α
  5. Newly synthesized mediators: leukotrienes (LTC4), prostaglandins (PGD2)
Janeway's Immunobiology 10e; Cellular and Molecular Immunology

Atopy and Genetic Determinants

"Atopic" individuals are genetically predisposed to produce specific IgE following allergen exposure. Key features:
  • Production of high IgE depends on a propensity to generate allergen-specific TFH cells secreting IL-4 and IL-13
  • Candidate genes: IL4, IL13, IL4R, STAT6 (chromosome 5q), HLA class II loci (chromosome 6p), FcεRI α chain locus (chromosome 1q23)
  • Allergen characteristics that favor IgE responses: MW 5-70 kDa, stable, glycosylated, soluble, often enzymatic activity (e.g., house dust mite cysteine protease, bee venom phospholipase A2)
  • Repeat exposure is required - first exposure sensitizes (IgE produced), second exposure triggers reaction
  • Non-protein antigens (e.g., penicillin) can cause IgE responses by acting as haptens bound to self proteins

Mast Cell Subtypes Relevant to IgE

FeatureMCT (mucosal)MCTC (connective tissue)
ContainsTryptase onlyTryptase + chymase
LocationMucosal surfaces, near T cellsSubmucosa, connective tissue
Allergic roleYes - at sites of allergic inflammationLess associated
MediatorsHigh LTC4, PGD2Less LTC4
IL-4 contentLowHigher

Clinical Diseases Associated with IgE

IgE-mediated (Type I Hypersensitivity)

  • Allergic rhinitis (hayfever)
  • Allergic asthma
  • Atopic dermatitis (eczema)
  • Urticaria (hives)
  • Food allergy
  • Anaphylaxis - systemic, life-threatening; IgE cross-linking in vascular system

Hyper-IgE Syndrome (Job Syndrome)

Characterized by markedly elevated IgE + eczema + eosinophilia + recurrent pulmonary infections + "cold" staphylococcal skin abscesses:
  • Autosomal dominant form: Heterozygous dominant-negative STAT3 mutations - impairs IL-6, IL-10, IL-17, IL-21, IL-22 signaling; reduces Th17 responses; increases IL-4/IL-13/Th9 driving IgE overproduction
  • Autosomal recessive form: DOCK8 mutations - reduced T, B, NK cells; defective lymphocyte signaling similar to Wiskott-Aldrich syndrome
Cellular and Molecular Immunology

Anti-IgE Therapy

Omalizumab (anti-IgE monoclonal antibody) targets free IgE and is used in:
  • Severe allergic asthma
  • Chronic urticaria
  • Other IgE-driven conditions
By binding free IgE, it reduces loading of mast cells and basophils, thereby blunting allergic responses.
Goodman & Gilman's Pharmacological Basis of Therapeutics

Laboratory Measurement

  • Total serum IgE: Normal reference range is low (typically < 100 IU/mL in adults); elevated in atopic disease, parasitic infections, Hyper-IgE syndrome
  • Specific IgE (sIgE): ImmunoCAP assay measures IgE directed against individual allergens; used in allergy diagnosis
  • Nasal specific IgE: Can be detected locally even when serum IgE is normal (entopy)
Henry's Clinical Diagnosis & Management by Laboratory Methods; Cummings Otolaryngology
Sources: Janeway's Immunobiology 10e | Cellular and Molecular Immunology | Henry's Clinical Diagnosis and Management by Laboratory Methods | Goodman & Gilman's Pharmacological Basis of Therapeutics | Cummings Otolaryngology
This is a shared conversation. Sign in to Orris to start your own chat.